Loading...

The effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studies

BACKGROUND: Reducing the severity of respiratory symptoms is a key goal in the treatment of chronic obstructive pulmonary disease (COPD). We evaluated the effect of aclidinium bromide 400 μg twice daily (BID) on respiratory symptoms, assessed using the Evaluating Respiratory Symptoms in COPD (E-RS(™...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Respir Res
Main Authors: Jones, Paul W., Leidy, Nancy K., Hareendran, Asha, Lamarca, Rosa, Chuecos, Ferran, Garcia Gil, Esther
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877996/
https://ncbi.nlm.nih.gov/pubmed/27215749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0372-1
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!